Skip to main content

Protein inhibitor may be a game changer for oncolytic therapies

Oncolytic viruses have been lauded as “the next major breakthrough” in cancer treatment, but have had limited success in human trials. Chinese researchers have landed on a compound that could boost the cancer-killing ability of these viruses.

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2023 Esophageal Cancer Education Foundation- by domino